Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals Ownership Summary
Tarsus Pharmaceuticals is owned by 120.44% institutional investors, 2.69% insiders. Blackrock is the largest institutional shareholder, holding 9.25% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.05% of its assets in Tarsus Pharmaceuticals shares.
TARS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tarsus Pharmaceuticals | 120.44% | 2.69% | -23.14% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.27M | 9.25% | $88.79M |
| Blackrock funding, inc. /de | 3.87M | 8.91% | $303.94M |
| Deep track capital, lp | 3.67M | 8.54% | $230.79M |
| Rtw investments, lp | 3.36M | 7.81% | $211.29M |
| Fmr | 3.27M | 7.54% | $250.40M |
| Paradigm biocapital advisors lp | 2.78M | 6.46% | $174.70M |
| Cowen and company | 2.20M | 6.22% | $59.72M |
| Vanguard group | 2.40M | 5.63% | $196.48M |
| Janus henderson group | 2.24M | 5.24% | $157.22M |
| Vanguard capital management | 1.88M | 4.33% | $147.71M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 1.57M | 4.48% | $98.71M |
| Deep track capital, lp | 3.67M | 3.36% | $230.79M |
| Paradigm biocapital advisors lp | 2.78M | 3.27% | $174.70M |
| Cutter capital management, lp | 112.50K | 2.55% | $6.23M |
| Tri locum partners lp | 328.34K | 2.54% | $20.67M |
| Ghost tree capital | 235.00K | 2.00% | $6.39M |
| Highvista strategies | 90.43K | 1.87% | $7.11M |
| Rtw investments, lp | 3.36M | 1.80% | $211.29M |
| Cowen and company | 2.20M | 1.64% | $59.72M |
| Vestal point capital, lp | 1.05M | 1.54% | $66.09M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 3.27M | 0.01% | 2.60M |
| Millennium management | 1.43M | 0.03% | 862.54K |
| Vestal point capital, lp | 1.05M | 1.54% | 850.00K |
| Blackrock | 3.27M | 0.00% | 614.03K |
| Abrdn | 505.59K | 0.05% | 505.59K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Macquarie group | - | - | -833.44K |
| Driehaus capital management | 317.58K | 0.12% | -608.55K |
| Vivo capital | - | - | -565.55K |
| Adage capital partners gp | - | - | -543.00K |
| Lord, abbett | - | - | -479.27K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Abrdn | 505.59K | 0.05% | 505.59K | $39.74M |
| Parkman healthcare partners | 150.00K | 0.97% | 150.00K | $9.44M |
| Marshall wace, llp | 148.55K | 0.01% | 148.55K | $11.68M |
| Cutter capital management, lp | 112.50K | 2.55% | 112.50K | $6.23M |
| Cubist systematic strategies | 73.95K | 0.02% | 73.95K | $4.40M |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -1.00 |
| Turning point benefit group | -2.00 |
| Hughes financial services | -2.00 |
| Capital performance advisors llp | -5.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 264 | -2.22% | 52,265,323 | 9.66% | 120 | 1.00% | 150 | 3.45% | 81 | -7.95% |
| Jun 30, 2026 | 268 | 3.08% | 47,623,821 | 5.50% | 110 | 1.00% | 145 | 5.84% | 86 | 4.88% |
| Mar 31, 2026 | 162 | -35.20% | 17,007,525 | -61.39% | 39 | 0.37% | 79 | -42.34% | 60 | -29.41% |
| Dec 31, 2025 | 158 | -29.15% | 24,700,440 | -44.97% | 57 | 0.52% | 84 | -21.50% | 52 | -41.57% |
| Sep 30, 2025 | 217 | 10.15% | 44,818,385 | 5.19% | 105 | 1.05% | 105 | -17.32% | 85 | 80.85% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.30M | 3.05% | 6.11K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.40M | 2.99% | 98.73K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.30M | 2.97% | 6.11K |
| First Trust NYSE Arca Biotech ETF | 1.34M | 2.86% | - |
| Vanguard US Total Market Shares ETF | 1.14M | 2.73% | - |
| iShares Russell 2000 ETF | 1.06M | 2.15% | - |
| Macquarie Small Cap Growth C | 478.19K | 1.13% | -73.10K |
| Invesco Small Cap Value A | 457.84K | 1.09% | -51.75K |
| Vanguard Institutional Extnd Mkt Idx Tr | 456.16K | 1.04% | 767.00 |
| RTW Biotech Opportunities Ord | 401.31K | 0.96% | 401.31K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $803.10K |
| Sep 15, 2026 | LINK WILLIAM J PHD | - | Sell | $59.96K |
| Sep 15, 2026 | LINK WILLIAM J PHD | - | Sell | $914.50K |
| Sep 15, 2026 | LINK WILLIAM J PHD | - | Sell | $5.28K |
| Sep 04, 2026 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $264.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q3 | - | 14 |
| 2026 Q2 | - | 6 |
| 2026 Q1 | - | 30 |
| 2025 Q4 | - | 9 |
TARS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools